Stay updated with breaking news from Initial Stockholders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Initiated discussions with FDA regarding accelerated approval pathway for CNM-Au8® for the treatment of ALS with the objective of submitting an NDA in 2024Released long-term data from the open-label extension
ROTH CH ACQUISITION V CO. 888 San Clemente Drive, Suite 400 Newport Beach, CA 92660 SUPPLEMENT NO. 2 TO PROXY STATEMENT DATED...
ROTH CH ACQUISITION V CO. 888 San Clemente Drive, Suite 400 Newport Beach, CA 92660 SUPPLEMENT TO PROXY STATEMENT DATED NOVEMBER...
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Stockholders and Board of Directors of Four Leaf Acquisition Corporation ...
ALS biomarker and long-term clinical data expected mid-yearNeurology expert Ben Greenberg, M.D., M.H.S., joined as Head of Medical SALT LAKE CITY, May ...